Johnson & Johnson (NYSE:JNJ) Stake Boosted by Affiance Financial LLC

A number of other institutional investors also recently modified their holdings of JNJ. Selective Wealth Management bought a new stake in shares of Johnson & Johnson in the 3rd quarter valued at $105,000. Financial Gravity Wealth Inc. acquired a new stake in shares of Johnson & Johnson during the first quarter worth $105,000. WP Advisors LLC purchased a new position in Johnson & Johnson in the second quarter worth $108,000. Fusion Family Wealth LLC now owns 1,010 shares of the company's stock worth $123,000 after acquiring an additional 870 shares in the last quarter. Finally, Live Your Vision LLC boosted its stake in shares of Johnson & Johnson by 58.3% in the 2nd quarter. The institutional investor owned 19,794 shares of the company's stock after purchasing an additional 392 shares during the period. $100,050 worth of Johnson & Johnson (NYSE:JNJ) shares were bought by MULCAHY ANNE M. PRINCE CHARLES had bought 2,000 shares worth $268,731 on Friday, December 14. The stock was sold at an average price of $147.31, for a total transaction of $536,650.33. Moreover, Wallington Asset Mngmt Limited Company has 3.05% invested in Johnson & Johnson (NYSE:JNJ) for 92,320 shares. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

In other Johnson & Johnson news, insider Joaquin Duato sold 40,000 shares of the company's stock in a transaction on Wednesday, November 7th.

The stock price weekly volatility remained at 1.43% while volatility is standing at 2.01% for the month while A beta factor is used to measure the volatility of the stock. Following the completion of the transaction, the chief executive officer now directly owns 481,254 shares of the company's stock, valued at approximately $70,243,833.84. The disclosure for this sale can be found here. In the last three months, insiders have sold 514,187 shares of company stock valued at $74,951,528. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: "5 Top Stock Trades for Wednesday: JNJ, CMG, MO, EBAY -" published on January 22, 2019 as well as's news article titled: "J&J teams up with Apple in heart health program - Seeking Alpha" with publication date: January 17, 2019. Highstreet Asset has 1.65% invested in Johnson & Johnson (NYSE:JNJ) for 215,250 shares. It's also very liquid in the near term, with a current ratio of 1.7. It rose 1.24% in recent trade and now has a stock-market value of $350.67B. Financial Incorporated stated it has 0.04% in Johnson & Johnson (NYSE:JNJ). Investors holded 1.84 billion in 2018Q2 but now own 1.70 billion shares or 7.91% less. The business had revenue of $20.39 billion for the quarter, compared to analyst estimates of $20.27 billion. To put some perspective around this, the industry's average net margin is 11.08%. The company's quarterly revenue was up 1.0% compared to the same quarter a year ago.

A big jump in prescription drug sales, particularly overseas, helped Johnson & Johnson swing to a large fourth-quarter profit after posting a huge loss a year earlier, when it took a $13.6 billion charge related to the late-2017 USA tax overhaul.

Earnings in the latest quarter, adjusted for one-time gains and costs, came to $1.97 per share, 2 cents better than expected. This buyback authorization authorizes the company to purchase up to 1.5% of its stock through open market purchases. Shares buyback plans are usually an indication that the company's management believes its stock is undervalued.

Wargroove’s PlayStation 4 Release Date Is Up in the Air
And Nintendo had been highly rumoured to be holding a Nintendo Direct for January 2019 with big announcements expected to be made. There is, however, also another reason, one where Nintendo's overarching family-friendly philosophy may have helped immensely.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 12th. Transamerica Financial Advsr has 0.22% invested in Johnson & Johnson (NYSE:JNJ) for 7,480 shares.

Moving ahead, if we take a look at what all stock market pros are now saying about Johnson & Johnson (NYSE:JNJ), the mean rating for this stock is 2.33. The ex-dividend date is Monday, February 25th. Johnson & Johnson's dividend payout ratio (DPR) is presently 44.01%.

In total 5 analysts cover Johnson \u0026 Johnson (NYSE:JNJ). Credit Suisse Group set a $149.00 price objective on shares of Johnson & Johnson and gave the company a "buy" rating in a research note on Sunday, October 14th. 7 are the (NYSE:JNJ)'s ratings reports on 24 Jan 2019 according to StockzIntelligence Inc. Citigroup maintained the stock with "Neutral" rating in Monday, October 22 report. Two research analysts have rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the company's stock. Morgan Stanley maintained it with "Equal-Weight" rating and $130 target in Wednesday, January 2 report. If you are accessing this piece on another domain, it was stolen and republished in violation of U.S. & worldwide trademark and copyright law. The correct version of this report can be accessed at

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The Company's Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.